Negishi virus envelope glycoprotein (134088-85-0)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- glycoprotein gH, pseudorabies virus
- glycoprotein B, infectious laryngotracheitis virus
- Antigen MEP 1(hepatitis B virus synthetic envelope reduced) (9CI)
- Glycoprotein (mousepneumonia virus strain 15) (9CI)
- Glycoprotein(rabies virus protein moiety reduced) (9CI)
- Protein(hepatitis C virus quasispecies 4E gene E2 envelope 2 N-terminal fragment)
- Glycoprotein F0 (phociddistemper virus strain Ulster/88 precursor reduced) (9CI)
- herpes simplex virus I glycoprotein B*fragment 49
- Glycoprotein gp 35(hepatitis C virus clone C10-E12 reduced) (9CI)
- Glycoprotein GNS(bovine ephemeral fever virus strain BB7721 clone G1.A6/G2.C1 nonstructuralreduced) (9CI)
- Glycoprotein G (bovineephemeral fever virus strain BB7721 clone G1.A6/G2.C1 reduced) (9CI)
- Glycoprotein E 2(rubella virus strain M33 precursor protein moiety reduced) (9CI)
- ImmunoglobulinG1, anti-(rabies virus glycoprotein) (human monoclonal CR4098 heavy chain),disulfide with human monoclonal CR4098 k-chain, dimer
- ImmunoglobulinG1, anti-(rabies virus glycoprotein) (human monoclonal CR57 heavy chain),disulfide with human monoclonal CR57 l-chain, dimer
- rubella E1 envelope protein
- inner envelope membrane protein 37K precursor
- vaccinia virus 42kDa protein
- B18R protein, vaccinia virus
- B15R protein, vaccinia virus
- Pseudorabies virusPseudorabies virus 3Pseudorepanduline
